Description:
GLYCOGEN STORAGE DISEASE III
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Carbohydrate Metabolism |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
9 |
|
amylo-alpha-1,6-glucosidase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.2.1.33; <10% activity. |
|
Remarks |
Formerly GM00055; less than 10% of normal debrancher enzyme activity |
Rossiaud L, Pellier E, Benabides M, Nissan X, Ronzitti G, Hoch L, Generation of three induced pluripotent stem cell lines from patients with glycogen storage disease type III Stem cell research72:103214 2023 |
PubMed ID: 37769385 |
dbSNP |
dbSNP ID: 22956 |
Gene Ontology |
GO:0004134 4-alpha-glucanotransferase activity |
|
GO:0004135 amylo-alpha-1,6-glucosidase activity |
|
GO:0005975 carbohydrate metabolism |
|
GO:0005978 glycogen biosynthesis |
|
GO:0016757 transferase activity, transferring glycosyl groups |
|
GO:0016798 hydrolase activity, acting on glycosyl bonds |
|
GO:0043033 isoamylase complex |
NCBI Gene |
Gene ID:178 |
NCBI GTR |
232400 GLYCOGEN STORAGE DISEASE III; GSD3 |
OMIM |
232400 GLYCOGEN STORAGE DISEASE III; GSD3 |
Omim Description |
AMYLO-1,6-GLUCOSIDASE DEFICIENCY; AGL DEFICIENCY |
|
CORI DISEASE |
|
FORBES DISEASE |
|
GLYCOGEN DEBRANCHER DEFICIENCY; GDE DEFICIENCY |
|
GLYCOGEN DEBRANCHER ENZYME, INCLUDED; GDE, INCLUDED |
|
GLYCOGEN DEBRANCHING DEFICIENCYAMYLO-1,6-GLUCOSIDASE, 4-ALPHA-GLUCANOTRANSFERASE, INCLUDED; AGL,INCLUDED |
|
GLYCOGEN STORAGE DISEASE III |
|
LIMIT DEXTRINOSIS |
Passage Frozen |
9 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|